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Abstract
Methods are presented to incorporate polymer-based bioactive matrices into micro-fabricated
implantable microelectrode arrays. Using simple techniques, hydrogels infused with bioactive
molecules are deposited within wells in the substrate of the device. This method allows local
drug delivery without increasing the footprint of the device. In addition, each well can be
loaded individually, allowing spatial and temporal control over diffusion gradients in the
microenvironment of the implanted neural interface probe. In vivo testing verified the
following: diffusion of the bioactive molecules, integration of the bioactive molecules with the
intended neural target and concurrent extracellular recording using nearby electrodes. These
results support the feasibility of using polymer gels to deliver bioactive molecules to the region
close to microelectrode shanks. This technique for microdrug delivery may serve as a means
to intervene with the initial phases of the neuroinflammatory tissue response to permanently
implanted microelectrode arrays.
(Some figures in this article are in colour only in the electronic version)
1. Introduction
Local drug delivery to a particular area within the body is a
widely held goal in the medical and biomedical engineering
communities. Several advantages arise from targeting specific
organs, tissues or micro-scale features at the desired site of
pharmacological action. Dosage can often be drastically
reduced, eliminating undue bodily stress and side effects
associated with systemic delivery. By physically limiting
the site of action, substances which affect multiple biological
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systems can be applied to specific purposes. This study is
particularly interested in local microscale neural drug delivery.
Neural systems research stands to benefit greatly from
targeted drug delivery. The blood–brain barrier presents
a challenge to systemically administered substances, often
increasing the necessary dosage. In addition, neural tissues
of similar cellular composition often have drastically different
functions based on anatomical location. This study focuses
on chronically implanted electrically-based neural interface
probes. These devices often suffer a loss of function over a
period of weeks to months because the neuroinflammatory
response produces a glial sheath surrounding the implant,
electrically isolating the probe from the surrounding tissue
[1]. Local drug delivery to the region surrounding the implant
as a means to pharmacologically intervene with this process is
being actively pursued by several groups [2–5].
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In general, local microscale drug delivery to the
tissue surrounding neural implants has followed two basic
approaches. One method involves fabricating microfluidic
channels into the substrate of the probe allowing injection
of drugs into the tissue immediately surrounding the
opening [2, 5]. The other technique relies on polymer
surface coatings which support timed release of bioactive
chemicals [4, 6, 7]. Both are successful, but have
significant drawbacks. Integrated microfluidic channels
greatly complicate probe production, leading to lower yields
and more expensive fabrication costs. In addition, the channels
increase the footprint, or size, of the device, which may
further injure the surrounding tissue during the implantation
procedure. Polymer surface coatings could increase the
device’s dimensions as well, potentially adding a layer to the
surface that could range from tens to hundreds of micrometers
in thickness. The high surface area-to-volume ratio of the
coatings may reduce the ability for sustained delivery over
long periods of time, which could minimize its potential for
limiting the chronic neuroinflammatory response.
We present a method for targeted microscale drug delivery,
based on the polymer coating method, which eliminates some
of the disadvantages associated with conventional techniques.
In this method, micromachined ‘wells’ are fabricated into the
substrate of a MEMS (micro-electro-mechanical systems)-
based chronic implant. These ‘wells’ are holes that extend
through the device’s thickness and allow for the integration
of matrices (i.e. hydrogels) infused with bioactive substances.
Since the matrices replace substrate instead of adding to it,
the device’s footprint is not increased. The lower surface
area-to-volume ratio lends the technique to extended time-
release periods. Most significantly, the release sites are
localized within micrometers of individual electrodes, and
each well can be loaded with a different material, leading
to spatial and temporal control over diffusion profiles through
the surrounding microenvironment.
Numerous side-benefits arise from the technique as well.
Since the electrode is within microns of the well, gradients
of growth factors could be established to direct neurite
growth toward the recording site. The design of the wells
permits tissue growth through the substrate, which may anchor
the probe more firmly in place. Finally, this method of
local drug delivery extends beyond chronic neural implants.
The technique’s simplicity and effectiveness make it easily
adaptable to a wide range of implantable microdevices.
In summation, this research seeks to explore the
feasibility, consistency and functionality of this novel
method for targeted microscale drug delivery. First,
this technique’s feasibility will be validated by adapting
manufacturing processes so that devices are constructed with
the aforementioned wells and then developing methods with
which these wells can be filled with various bioactive matrices.
Next, we will investigate the consistency of these methods by
determining how reliably these devices can be fabricated and
how consistently the wells can be filled with a bioactive matrix.
Lastly, we will test the functionality of these devices by using
in vivo experiments to determine if the matrix is delivered to the
desired tissue, whether the devices survive implantation and
if the devices remain electrically viable. By answering these
questions, we will provide a solid foundation for future use
of these techniques in experiments attempting to minimize the
inflammatory response to the implantation of neural prosthetic
devices.
2. Materials and methods
Fabrication of the silicon- and polymer-based probes used in
this study has been previously described [8, 9]. Both types
of devices are planar structures designed to include small
wells of various shapes and sizes in the probe’s substrate.
These wells are typically located within 30 micrometers of
a recording site, although the exact placement is a variable
design parameter. The wells are rectangular or elliptical with
dimensions ranging from 20 to 60 µm wide and extending the
depth of the substrate, generally 7 µm to 20 µm deep.
2.1. Gels
To demonstrate the robustness of the technique, three types
of matrices were used in order to cover a range of material
properties, including viscosity and release rates. The gels
utilized in this study were NeuroTrace R© Tissue Labeling
Paste (Molecular Probes Inc., Eugene, OR), NeuroSeal dural
sealant (NeuroNexus Technologies, Ann Arbor, MI) and
polypropylene glycol. In addition to using unmodified gels,
other substances were added to the matrices to demonstrate
the delivery and release of bioactive chemicals. To this end,
NeuroTrace R© pastes containing lipophilic fluorescent tracers
DiI, DiO and DiD (stock from Molecular Probes, Inc.) were
used. Lyophilized nerve growth factor (NGF, Sigma Inc.) was
added to NeuroTrace R© paste that did not contain fluorescent
dye. Green dye was mixed into unreacted alginate portion
of the NeuroSeal and polypropylene glycol to provide for
visualization of the normally translucent materials. Both
alginate and polypropylene glycol were applied to the probes
in their liquid states.
2.2. Method to fill probe wells
Two basic micropipetting methods were developed to
selectively and reliably fill individual probe wells with the
gels (figure 1(A) and (B)). For both, micropipettes of various
tip sizes and lengths were fabricated from borosilicate glass
tubing using a micropipette puller (Sutter Instruments, Navato,
CA). The typical inside tip diameter was approximately 10 µm,
although this was adjusted according to material viscosity and
well dimensions. The ‘injection method’ for filling wells
with the polypropylene gel involved aspirating the liquid
into a micropipette and then injecting it, under pressure,
into the wells (figure 1(A)). The second method, ‘droplet
deposition’ (figure 1(B)), involved suspending a drop of gel
from the micropipette tip and then depositing the drop into the
well by bringing the gel into contact with the probe using
micropositioners (Eppendorf, Westbury, NY). The droplet
deposition method was the preferred approach for the more








Figure 1. Illustration of electrode well seeding technique.
Schematics of the device and pipette depicting the injection and
droplet deposition methods prior to gel loading are given in (A) and
(B), respectively, (C) schematic of a device with a filled well,
(D) fluorescent image of probe immediately after the gel loading
and subsequent withdrawal of pipette tip. The edges of the probe
appear red due to internal reflection of the fluorescing DiI emanating
from the well through the polyimide substrate. The volume of gel
contained within the well is approximately 9 picoliters based on the
well dimensions and (E) shows a polyimide based electrode with a
seeded well in the middle of a tetrode arrangement of recording sites.
the probe shank was suspended by clamping it between
microscope-slide-cover slips to prevent capillary forces from
pulling fluid from the well along the probe’s bottom.
All animal-use procedures were approved by the
Institutional Animal Care and Use Committee at Arizona State
University.
3. Results
Two techniques for filling micromachined wells within MEMS
devices, injection and droplet deposition, were evaluated.
With proficiency, both were simple to perform, taking
approximately 30 minutes for set-up, filling four wells with a
single-gel type and probe removal. Both techniques produced
high yield, with proper filling of four wells on a multi-
shank probe occurring greater than 90% of the time. Precise
volume control was not necessary, as both injection and
droplet deposition filled the wells through capillary action.
Loading separate gels into different wells was easily achieved
(figure 2(A) and (B)), as was loading two gels into a single
well (figure 2(C) and (D)). However, increasing the number of
gel types decreased yield and increased filling time per device.
Four gel types were successfully loaded into wells in
both silicon and polyimide devices. To deliver high viscosity
gels, droplet deposition was the preferred technique since
aspiration into and ejection from a small pipette tip using
high pressure was difficult and inaccurate. For lower viscosity




Figure 2. Seeding of multi-well devices with different gels.
(A) SEM micrograph of the base microelectrode technology. All
devices are 60 µm wide as shown, (B) loading of multiple wells,
each with a different gel, from left to right: polypropylene glycol
(green hue not visible due to microscope and camera settings), DiI
gel (bright red), no gel and calcium alginate (translucent red),
(C) focal delivery of DiI gel into one half of a silicon probe well and
(D) fluorescent image of a device immediately after focal delivery of
DiO gel into remaining half of the well. DiI fluorescence is shown
in red and DiO is shown in orange (in online version only).
both cases, the tip size of the pipette needed adjusting based
on gel properties (primarily viscosity) to deliver the proper
volume to the well. For the types and sizes of probes used,
neither well geometry nor probe substrate material influenced
the loading techniques. It was outside the aim of this study to
exhaustively explore all well geometries, gel types and probe
configurations. Evaporation during the process was both a
hindrance and a benefit. When occurring in the droplet at the
pipette tip, it concentrated the gel and occasionally clogged the
pipette. However, once deposited within a well, evaporation
solidified the gel in the proper location.
For proof-of-concept, several in vivo tests were carried out
on only a small number of animals (n = 2–5) to evaluate the
reliability of the device insertion and determine the feasibility
of using them in future, more thorough experiments. For these
experiments, seeded devices were UV-sterilized and implanted
in the somatosensory or motor cortex of anesthetized rats
using previously described surgical techniques [9]. At the
end of the evaluation period, each animal was euthanized and
its brain tissue prepared for subsequent histological analysis
using previously published methods in a complementary study
[1, 10]. Histological sections were imaged using transmitted
light, fluorescent and confocal microscopy techniques to verify
the techniques only. While no quantitative assessments
were carried out, qualitative evaluations were made on a
few samples. Additionally in some instances, brief daily
neural recordings were obtained for post-implantation periods
of up to four weeks using conventional neural recording
procedures for extracellular field potentials and spiketrains
[8, 9]. These recordings were taken only to verify electrode
functionality after matrix seeding and implantation, but were
not quantitatively analyzed for signal characteristics.
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Figure 3. Delivery of gel-seeded device into neural tissue. The
background of this figure shows an image taken using fluorescent
illumination where diffusion of the DiI gel from an implant can be
seen four hours post implantation. The dashed white rectangle
represents the approximate position of the electrode well in the
tissue. The plot (overlaid in yellow) shows the intensity profile for




Figure 4. Wells seeded with NGF. The upper left schematic (A) illustrates the layout of an implanted microelectrode array, showing the
relative position of the NGF-seeded well in relation to a recording site. In this four-shank implant, only one of the shanks has an
NGF-seeded well. The implanted animal was sacrificed after 40 days, sectioned at the level of the NGF-seeded well, and
immunohistochemically stained with antibodies against GFAP and the extracellular matrix protein, laminin. The lower left figure in this
layout (B) is a histological image from this implant. The site that contained the NGF-seeded well (second from the left in this image)
showed increased levels of matrix deposition versus the unseeded electrode shank sites. Part (C) shows the electrophysiological recordings
taken from two individual electrode sites closest to two different seeded wells, each at 40-days post-implantation. The inset image to the left
of each recording shows the pre-implant electrode with lyophilized NGF seeded in each well.
As seen in figure 3, gels remained inside the wells
throughout the implantation process. For a low percentage
of the time, some of the gel became dislodged during
implantation and was spread along the probe’s surface. Once
in place, the material within the wells began diffusing into the
tissue surrounding the electrode. A time-dependent diffusion
profile, controlled by the properties of the gel and solute,
was thus achieved (figure 3). This diffusion profile (for DiI
only) was determined by measuring the intensity profile for
the fluorescence intensity of the DiI from the center of the
well along its horizontal axis. Actual concentrations were not
determined as what appears to be a homogenous mixture on
the macroscale is often not when viewed on the microscale.
To demonstrate localized delivery of a bioactive substance,
figure 4 shows the results of an implant in which the well in
one shank of a four-shank probe was filled with NeuroTrace R©
mixed with lyophilized NGF. Following a 40-day post-implant
L26
Communication
period, the animal was euthanized for histological analysis.
Qualitative observations of figure 4(B) show a notable tissue
response in the form of laminin deposition seen as a green
‘cloud’ over and adjacent to the site of NGF release from
the gel. Additionally, an increased level of GFAP expression
(yellow stained cells) can be seen around the implant sites.
These results are typical for the sites of NGF seeding (n = 4),
but noticeably different from the well sites without NGF
(n = 28), which all showed a relatively normal response (in
comparison to previous studies [8]). A two-second sample of
the extracellular recordings taken from two different recording
sites, each located 15 micrometers from two different seeded
wells is given in figure 4(C). These recordings demonstrate that
the sites near the NGF-seeded wells remain electrically viable
following implantation. The recordings shown are typical
for the sites adjacent to the NGF-seeded wells, although not
statistically different from the other sites in the array. In all
the animals that were implanted with functioning electrodes
(n = 4, 48 hours and 40 days), neural signals were recorded
from the sites adjacent to the wells that had been seeded
with bioactive molecules. Qualitatively, the electrodes were
able to record unit activity with acceptable signal amplitude
(figure 4), as would be expected from the investigators’
experiences with these types of electrodes [8].
4. Discussion
This study describes a new technique for multi-site, localized
drug delivery using penetrating neural probes. First, wells
are micromachined into the device substrate at various sites.
Next, a hydrogel containing a bioactive substance is loaded
into each well individually. Upon implantation, the hydrogel
releases the drug via diffusion into the surrounding tissue. The
combination of these features results in several advantages
over conventional drug-delivery techniques such as polymer
coatings or microfluidic channels for fluid injection.
The use of micromachined wells provides a number
of benefits. Perhaps the most obvious advantage is the
ability to integrate bioactive substances into the device
without increasing the footprint, or cross-sectional area, of
the implant. Both surface coatings and integrated microfluidic
channels increase the device dimensions, potentially leading
to increased tissue damage during implantation and a larger
volume of foreign materials remaining lodged within the
tissue. In contrast, wells located in the probe substrate do
not increase tissue damage during the implant procedure,
and a smaller volume of foreign material is left within the
tissue once the hydrogel has dissipated. Another benefit arises
from the possibility of inducing cellular growth through the
holes, which, if achievable, may serve to physically anchor
the implant into the surrounding tissue. Particularly for
electrically-based probes, any reduction of device movement
post-implantation would aid in the localization of electrical
signals and their subsequent assignment to individual cells.
Another important aspect of this method is the general
ease and success of the well-filling techniques. Since
the methods are effective regardless of substrate material,
well geometry and gel/drug material, these variables remain
unconstrained as design parameters. For example, consider
time-controlled drug release into the local tissue surrounding
the implant. Compared to polymer surface coatings, hydrogels
deposited in wells have a much lower surface area-to-volume
ratio, leading to a more prolonged diffusion profile. Prolonged
release is often desirable when attempting to control conditions
such as the neuroinflammatory response over a span of hours
to days.
However, the true benefit regarding time-controlled drug
release is realized through the ability to potentially manipulate
the diffusion profile through variable parameters such as well
geometry and gel material. Hydrogels contained within small
aspect-ratio holes have low surface area-to-volume ratios,
leading to slower drug release rates. A larger aspect-ratio hole
would increase the surface area-to-volume ratio, thus speeding
up diffusion into the tissue [11, 12]. Additionally, gels with
differing properties may be used to influence both the duration
and rate of drug release.
The ability to precisely orient micromachined wells in
implantable devices opens up a wide variety of experimental
possibilities. Because the wells are formed as an integral
part of the microelectrode fabrication process, the position
and geometry of each well is a changeable design parameter.
Each well, depending on geometry, can deliver volumes
(in the range of tens of picoliters) to a location known
with micrometer accuracy. The amount of affected tissue
surrounding this location can be controlled by adjusting the
volume, concentration and release profile of the gel to coincide
with the time course of the biological events. As illustrated in
this study, chemical gradients (figure 3) can be centered within
micrometers of electrode sites (figure 1(D)). Therefore, it may
be feasible to attract neural growth to the specific location of
an electrode using growth factors and other chemical signaling
cues. Recording site proximity is particularly important if the
goal of the implant procedure is to measure the effect (e.g.
neurite extension, neural modulation, etc.) of the bioactive
molecule on neurons [5, 13, 14].
It was not a forgone conclusion that delivery of bioactive
molecules would not interfere with the adjacent electrodes’
ability to record unit activity. As seen in figure 4, the
electrodes remain electrically viable and continue to record
neural activity as the bioactive molecules diffuse into the local
extracellular space. In all of the animals that were implanted
with electrically functional implants (n = 4), the electrodes
adjacent to the seeded wells recorded neural activity (figure 4
is a typical response). This verifies that the process of filling
the wells and the subsequent diffusion of molecules into the
extracellular space does not appear to preclude the electrodes’
ability to record extracellular neural activity. The long-term
effects of diffusion of the bioactive molecules are yet to be
determined and will be the focus of future studies.
The capability for localized drug delivery is extended
by the use of multiple wells. By nature of the well-filling
technique, each well is loaded with polymer individually.
Utilizing wells containing various bioactive material
formulations allows the creation of a spatially and temporally
distributed chemical profile in the microenvironment of the
device. In this manner, a probe could deliver different drugs
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from selected sites, each with an independent delivery rate
profile [15].
The studies presented here hint at this technique’s
potential for use in delivering substances to neural tissue in
order to reduce inflammation, stimulate or minimize cellular
responses or treat neurological disorders. However, this
technique has already been practically implemented in a
concurrent study where these methods are used to deliver
fluorophores to neural tissue for visualization purposes. (See
‘Visualization of the intact interface between neural tissues
and implanted microelectrode arrays’ in this issue [10].)
This example illustrates the usefulness of this technique and
demonstrates its potential in secondary applications such as
in vivo imaging, anatomical tracing and electrode position
validation.
5. Conclusions
This study presents a straightforward method to achieve local,
time-controlled, multi-site microscale drug delivery within a
single device. Micromachined wells provide precise spatial
control, decrease the volume of the implant and, unlike other
techniques, do not require an increased footprint to achieve
delivery of bioactive substances. The simplicity of the well-
filling technique makes it amenable to multiple types of probe
materials and drug-infused polymers. Filling multiple wells
on a single probe with different substances allows greater
control of spatial and temporal drug release than is otherwise
possible. The major benefit of the work is to extend the design
parameters of chronic implantable neural interface devices,
giving the researcher greater control over multiple aspects of
probe functionality.
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